BioTechLogic News
BioTechLogic is in the news! Stop by for updates on our trade show appearances, speaking engagements, press coverage and more.
» Showing: April 2008
Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease (4/23/2008)
BRUSSELS (Belgium) - April 22, 2008— UCB announced today that the US Food and Drug Administration (FDA) has approved Cimzia® (certolizumab pegol), the first and only PEGylated anti-TNFa (Tumor Necrosis Factor alpha) antibody indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy.
Tracy TreDenick and Patrick Giljum Presenting at Northwestern University (4/16/2008)
BioTechLogic's Tracy TreDenick and Patrick Giljum will be teaching a session on US and EU Biologic Regulations at Northwestern University in Evanston, Illinois on April 22, 2008. The session is part of the Masters in Quality and Regulatory Science at Northwestern University's School of Continuous Studies.
BioTechLogic's Adeana Dorsey invited to join the Combination Products Coalition (CPC) (4/14/2008)
Adeana Dorsey, Manager, Regulatory Affairs and Quality Systems at BioTechLogic has been invited to join the Combination Products Coalition (CPC). In this role, she will provide consultative guidance, working with the FDA, in the development of GMP regulations and regulatory pathways for combination products.